New Delhi, Jan. 28 -- Cipla, one of the leading pharmaceutical companies in India, has released its December quarter numbers (Q3FY25) today, January 28, reporting a 48% YoY jump in its consolidated net profit to Rs.1,571 crore, driven by strong performance in Emerging Markets & Europe.

The generic drugmaker's total revenue from operations for Q3 FY25 stood at Rs.7,073 crore, compared to Rs.6,603 crore in Q3FY24, but remained flat compared to the preceding quarter's revenue of Rs.7,051 crore.

(more to come)

Published by HT Digital Content Services with permission from MINT....